4Moe SM, Drueke T, Lameire N, et al. Chronic kidney disease-mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis, 2007,14: 3-12.
5Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol, 2004, 15: 2208-2218.
6Friedman EA. Calcium-based phosphate binders appropriate in chronic renal failure. Clin J Am Soc Nephrol, 2006. 1: 704-709.
7Kovesdy CP, Mehrotra R, Kalantar-Zadeh K. Battleground: chronic kidney disorders mineral and bone disease-calcium obsession, vitamin d, and binder confusion. Clin J Am Soc Nephrol, 2008, 3: 168-173.
8Johansen KL, Chertow GM. Chronic kidney disease mineral bone disorder and health-related quality of life among incident end-stage renal-disease patients. J Ren Nutr, 2007,17: 305-313.
9Eknoyan G, Lameire N, Barsoum R, et al. The burden of kidney disease: improving global outcomes. Kidney Int, 2004, 66: 1310-1314.
10Chung SY, Chen TH, Lai SL, et al. Hypercalcemia and status epilepticus relates to salmon calcitonin administration in breast cancer. Breast, 2005, 14: 399-402.
